Kliensberg personal page - To The Moon

Kliensberg

Kliensberg

No personal profile

75Follow

4Followers

0Topic

0Badge

2021-01-29

Great

Sorry, the original content has been removed

2021-01-26

What are your views?

Stimulus that saved markets from collapse in 2020 now may be a key risk, warns Putnam Investments

2021-01-24

$CF Finance Acquisition Corp II(CFII)$Moving up soon?

2021-01-22

Poised to move soon.

2020-11-21

Great

Could Tesla and other auto makers see sales boom from Boris Johnson's ambitious plan for electric vehicles?

2021-05-28

$AMC Entertainment(AMC)$AMC to the moon

2021-02-13

$AMC Entertainment(AMC)$ sfill holding

2021-02-09

$AMC Entertainment(AMC)$faint

2021-08-09

Thanks

Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd

2021-06-26

Nice

Sorry, the original content has been removed

2021-02-17

$Velodyne Lidar Inc(VLDR)$ coming back up

2020-12-03

$AstraZeneca PLC(AZN)$ more to come

As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial

2020-11-30

Nice

Malaysia secures 12.8 mln doses of Pfizer vaccine, delivery from Q1

2021-08-09

$Proterra Inc.(PTRA)$ when is this gonna start moving?

2021-06-19

Solid Uptrend. Nice to hold

2021-03-17

$Golden Nugget Online Gaming, Inc.(GNOG)$sweet

2021-03-15

$Palantir Technologies Inc.(PLTR)$Resistant

2020-11-28

Yes

Sorry, the original content has been removed

2021-08-09

Moving up?

2021-06-26

Starting to move

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3567846245354832","uuid":"3567846245354832","gmtCreate":1604756688425,"gmtModify":1605927796560,"name":"Kliensberg","pinyin":"kliensberg","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":75,"tweetSize":72,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":898696118,"gmtCreate":1628490156434,"gmtModify":1703506956734,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Moving up?&nbsp;","listText":"Moving up?&nbsp;","text":"Moving up?","images":[{"img":"https://static.tigerbbs.com/1ec0ed27e46e45e9b203824a5eb3814e","width":"1176","height":"2548"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898696118","isVote":1,"tweetType":1,"viewCount":1763,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898698812,"gmtCreate":1628490129136,"gmtModify":1703506955585,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898698812","repostId":"2158413272","repostType":4,"repost":{"id":"2158413272","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628489696,"share":"https://ttm.financial/m/news/2158413272?lang=en_US&edition=fundamental","pubTime":"2021-08-09 14:14","market":"us","language":"en","title":"Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd","url":"https://stock-news.laohu8.com/highlight/detail?id=2158413272","media":"Reuters","summary":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt","content":"<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsraeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-09 14:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158413272","content_text":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.\nIsrael began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.\nIsrael's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/BioNTech SE vaccine to more than 240,000 people.\nAbout 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.\nEighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.\nThirty-one percent reported some side effect, the most common being soreness at the injection site.\nAbout 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.\nRan Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"\n\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898698113,"gmtCreate":1628490103032,"gmtModify":1703506955423,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>&nbsp;when is this gonna start moving?&nbsp;","listText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>&nbsp;when is this gonna start moving?&nbsp;","text":"$Proterra Inc.(PTRA)$ when is this gonna start moving?","images":[{"img":"https://static.tigerbbs.com/e92e515790b36221ea69f23ec118eb90","width":"1176","height":"2091"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898698113","isVote":1,"tweetType":1,"viewCount":1802,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125687952,"gmtCreate":1624671808276,"gmtModify":1703843242240,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125687952","repostId":"1100072036","repostType":4,"isVote":1,"tweetType":1,"viewCount":1707,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125685988,"gmtCreate":1624671744544,"gmtModify":1703843239114,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Starting to move&nbsp;","listText":"Starting to move&nbsp;","text":"Starting to move","images":[{"img":"https://static.tigerbbs.com/6998f7db0638d20fa40c753e04a4f0ac","width":"1080","height":"3528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125685988","isVote":1,"tweetType":1,"viewCount":1655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":162579628,"gmtCreate":1624069582664,"gmtModify":1703828121467,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Solid Uptrend. Nice to hold","listText":"Solid Uptrend. Nice to hold","text":"Solid Uptrend. Nice to hold","images":[{"img":"https://static.tigerbbs.com/702f12b398d11c5c3f9fe42025a6e0d3","width":"1080","height":"3021"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162579628","isVote":1,"tweetType":1,"viewCount":1896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":184805226,"gmtCreate":1623696132965,"gmtModify":1704208936296,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Risky play","listText":"Risky play","text":"Risky play","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184805226","repostId":"2143378010","repostType":4,"isVote":1,"tweetType":1,"viewCount":1922,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134962623,"gmtCreate":1622201527662,"gmtModify":1704181362783,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>AMC to the moon&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>AMC to the moon&nbsp;","text":"$AMC Entertainment(AMC)$AMC to the moon","images":[{"img":"https://static.tigerbbs.com/025259f414ec0ae367ce5aa5cb887d56","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/134962623","isVote":1,"tweetType":1,"viewCount":1697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":350156620,"gmtCreate":1616168807560,"gmtModify":1704791870993,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Finally moving in the right direction&nbsp;","listText":"Finally moving in the right direction&nbsp;","text":"Finally moving in the right direction","images":[{"img":"https://static.tigerbbs.com/8eebd5986b153910a99af33c71a7ebba","width":"1080","height":"2989"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350156620","isVote":1,"tweetType":1,"viewCount":1528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":350158553,"gmtCreate":1616168764872,"gmtModify":1704791869858,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Will it kiss 300?","listText":"Will it kiss 300?","text":"Will it kiss 300?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350158553","repostId":"1136440314","repostType":4,"isVote":1,"tweetType":1,"viewCount":1498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325495703,"gmtCreate":1615910671202,"gmtModify":1704788429833,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GNOG\">$Golden Nugget Online Gaming, Inc.(GNOG)$</a>sweet","listText":"<a href=\"https://laohu8.com/S/GNOG\">$Golden Nugget Online Gaming, Inc.(GNOG)$</a>sweet","text":"$Golden Nugget Online Gaming, Inc.(GNOG)$sweet","images":[{"img":"https://static.tigerbbs.com/f2175d49aa0cb0dcad79a965f9560cb2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325495703","isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":325495602,"gmtCreate":1615910635606,"gmtModify":1704788429025,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Up till 20","listText":"Up till 20","text":"Up till 20","images":[{"img":"https://static.tigerbbs.com/2cd1e093f9749d764e5427d623a241ea","width":"1080","height":"2989"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325495602","isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":322470890,"gmtCreate":1615823180610,"gmtModify":1704787179066,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Resistant","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Resistant","text":"$Palantir Technologies Inc.(PLTR)$Resistant","images":[{"img":"https://static.tigerbbs.com/54d7babda19ab683c6cbb784cec56b51","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322470890","isVote":1,"tweetType":1,"viewCount":763,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":322450405,"gmtCreate":1615821922707,"gmtModify":1704787153778,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>hodll","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>hodll","text":"$AMC Entertainment(AMC)$hodll","images":[{"img":"https://static.tigerbbs.com/22e650de7b32fde5001c98b732d7f6a9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322450405","isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":385691665,"gmtCreate":1613538836357,"gmtModify":1704881775963,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VLDR\">$Velodyne Lidar Inc(VLDR)$</a>&nbsp;coming back up","listText":"<a href=\"https://laohu8.com/S/VLDR\">$Velodyne Lidar Inc(VLDR)$</a>&nbsp;coming back up","text":"$Velodyne Lidar Inc(VLDR)$ coming back up","images":[{"img":"https://static.tigerbbs.com/a1bc60471bf7e264b96225a50de95d34","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/385691665","isVote":1,"tweetType":1,"viewCount":506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":386516865,"gmtCreate":1613202526157,"gmtModify":1704879418999,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>&nbsp;sfill holding&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>&nbsp;sfill holding&nbsp;","text":"$AMC Entertainment(AMC)$ sfill holding","images":[{"img":"https://static.tigerbbs.com/6df28e4106b8fa8654cbe8fab9de17e1","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/386516865","isVote":1,"tweetType":1,"viewCount":757,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3567570068519334","authorId":"3567570068519334","name":"胜利曙光","avatar":"https://static.tigerbbs.com/ef4fea1c9347fef2d43cbf3fa476b33e","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3567570068519334","idStr":"3567570068519334"},"content":"Still holding too","text":"Still holding too","html":"Still holding too"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":386516105,"gmtCreate":1613202473707,"gmtModify":1704879418676,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Flying non stop","listText":"Flying non stop","text":"Flying non stop","images":[{"img":"https://static.tigerbbs.com/ff1b9030fdf45a0869c4a5821c055923","width":"1080","height":"3088"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/386516105","isVote":1,"tweetType":1,"viewCount":444,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":381970242,"gmtCreate":1612925575686,"gmtModify":1704876094745,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Target 80","listText":"Target 80","text":"Target 80","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/381970242","isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":381944365,"gmtCreate":1612925425357,"gmtModify":1704876090964,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SBE\">$Switchback Energy Acquisition Corporation(SBE)$</a>&nbsp;going further up?&nbsp;","listText":"<a href=\"https://laohu8.com/S/SBE\">$Switchback Energy Acquisition Corporation(SBE)$</a>&nbsp;going further up?&nbsp;","text":"$Switchback Energy Acquisition Corporation(SBE)$ going further up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/381944365","isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":383898324,"gmtCreate":1612862045468,"gmtModify":1704875057115,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Moving soon&nbsp;","listText":"Moving soon&nbsp;","text":"Moving soon","images":[{"img":"https://static.tigerbbs.com/0afbd49607027b0614e8bc959369c6c4","width":"1080","height":"3088"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/383898324","isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":318235197,"gmtCreate":1611853679719,"gmtModify":1704864927856,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/318235197","repostId":"2107267008","repostType":2,"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":319779736,"gmtCreate":1611629204525,"gmtModify":1704861499390,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"What are your views?&nbsp;","listText":"What are your views?&nbsp;","text":"What are your views?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/319779736","repostId":"2106092429","repostType":4,"repost":{"id":"2106092429","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1611624300,"share":"https://ttm.financial/m/news/2106092429?lang=en_US&edition=fundamental","pubTime":"2021-01-26 09:25","market":"sg","language":"en","title":"Stimulus that saved markets from collapse in 2020 now may be a key risk, warns Putnam Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2106092429","media":"Dow Jones","summary":"Financial markets avoided collapse last year when the coronavirus first cut a deadly path across the","content":"<p>Financial markets avoided collapse last year when the coronavirus first cut a deadly path across the globe, largely because the U.S. and other developed nations rolled out trillions of dollars' worth of pandemic stimulus.</p>\n<p>The quick deployment of fiscal and monetary aid helped keep global economies .</p>\n<p>But as COVID-19 vaccines roll out, albeit with fits and starts in the U.S., financial markets could risk running on a \"sugar high,\" according to Putnam Investments, a global money manager with $192 billion in assets under management.</p>\n<p>From Putnam's standpoint, a key risk in 2021 is a further \"melt up\" in risk assets. \"It would be driven in part by the very same policy stimulus that has helped protect the global economy from collapse,\" Putnam's Jason Vaillancourt, co-head of global asset allocation, wrote in a co-authored first-quarter outlook distributed Monday. \"Nobody rings a bell at the top.\"</p>\n<p>The S&amp;P 500 index and technology-heavy Nasdaq Composite Index closed out Monday at record highs, even as the Dow Jones Industrial Average extended its losing streak to a third straight session.</p>\n<p>After the closing bell, Janet Yellen was confirmed as the first female U.S. Treasury secretary in history, roughly a week after she urged lawmakers to \"act big\" now to save the economy and worry about the debt later.</p>\n<p>See: Janet Yellen wins Senate confirmation as Treasury secretary</p>\n<p>Yellen, formerly a Federal Reserve chair during the recovery phase of the global financial crisis, has been a well-known voice on Capitol Hill. That could be helpful in drawing support from both sides of the political aisle as President Joe Biden fights for an additional $1.9 trillion pandemic fiscal spending package and his coming infrastructure bill.</p>\n<p>The call for additional aid for U.S. households, businesses and cities hard-hit by the pandemic comes as investors around the globe continue to hunt for any additional upside that might be squeezed out of financial markets, following more than a decade of low rates and easy-money policies and a growing U.S. budget deficit .</p>\n<p>Still, Vaillancourt's team at Putnam sees how U.S. stocks \"could potentially rip higher,\" even though there already are showing \"strong parallels with those heady dot-com days\" that bear watching, including multibillion-dollar valuations for companies with \"little to show for revenue,\" insiders selling equity and the rise of special-purpose acquisition companies, or SPACS, that have raised large sums through initial public offerings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stimulus that saved markets from collapse in 2020 now may be a key risk, warns Putnam Investments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStimulus that saved markets from collapse in 2020 now may be a key risk, warns Putnam Investments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-01-26 09:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Financial markets avoided collapse last year when the coronavirus first cut a deadly path across the globe, largely because the U.S. and other developed nations rolled out trillions of dollars' worth of pandemic stimulus.</p>\n<p>The quick deployment of fiscal and monetary aid helped keep global economies .</p>\n<p>But as COVID-19 vaccines roll out, albeit with fits and starts in the U.S., financial markets could risk running on a \"sugar high,\" according to Putnam Investments, a global money manager with $192 billion in assets under management.</p>\n<p>From Putnam's standpoint, a key risk in 2021 is a further \"melt up\" in risk assets. \"It would be driven in part by the very same policy stimulus that has helped protect the global economy from collapse,\" Putnam's Jason Vaillancourt, co-head of global asset allocation, wrote in a co-authored first-quarter outlook distributed Monday. \"Nobody rings a bell at the top.\"</p>\n<p>The S&amp;P 500 index and technology-heavy Nasdaq Composite Index closed out Monday at record highs, even as the Dow Jones Industrial Average extended its losing streak to a third straight session.</p>\n<p>After the closing bell, Janet Yellen was confirmed as the first female U.S. Treasury secretary in history, roughly a week after she urged lawmakers to \"act big\" now to save the economy and worry about the debt later.</p>\n<p>See: Janet Yellen wins Senate confirmation as Treasury secretary</p>\n<p>Yellen, formerly a Federal Reserve chair during the recovery phase of the global financial crisis, has been a well-known voice on Capitol Hill. That could be helpful in drawing support from both sides of the political aisle as President Joe Biden fights for an additional $1.9 trillion pandemic fiscal spending package and his coming infrastructure bill.</p>\n<p>The call for additional aid for U.S. households, businesses and cities hard-hit by the pandemic comes as investors around the globe continue to hunt for any additional upside that might be squeezed out of financial markets, following more than a decade of low rates and easy-money policies and a growing U.S. budget deficit .</p>\n<p>Still, Vaillancourt's team at Putnam sees how U.S. stocks \"could potentially rip higher,\" even though there already are showing \"strong parallels with those heady dot-com days\" that bear watching, including multibillion-dollar valuations for companies with \"little to show for revenue,\" insiders selling equity and the rise of special-purpose acquisition companies, or SPACS, that have raised large sums through initial public offerings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2106092429","content_text":"Financial markets avoided collapse last year when the coronavirus first cut a deadly path across the globe, largely because the U.S. and other developed nations rolled out trillions of dollars' worth of pandemic stimulus.\nThe quick deployment of fiscal and monetary aid helped keep global economies .\nBut as COVID-19 vaccines roll out, albeit with fits and starts in the U.S., financial markets could risk running on a \"sugar high,\" according to Putnam Investments, a global money manager with $192 billion in assets under management.\nFrom Putnam's standpoint, a key risk in 2021 is a further \"melt up\" in risk assets. \"It would be driven in part by the very same policy stimulus that has helped protect the global economy from collapse,\" Putnam's Jason Vaillancourt, co-head of global asset allocation, wrote in a co-authored first-quarter outlook distributed Monday. \"Nobody rings a bell at the top.\"\nThe S&P 500 index and technology-heavy Nasdaq Composite Index closed out Monday at record highs, even as the Dow Jones Industrial Average extended its losing streak to a third straight session.\nAfter the closing bell, Janet Yellen was confirmed as the first female U.S. Treasury secretary in history, roughly a week after she urged lawmakers to \"act big\" now to save the economy and worry about the debt later.\nSee: Janet Yellen wins Senate confirmation as Treasury secretary\nYellen, formerly a Federal Reserve chair during the recovery phase of the global financial crisis, has been a well-known voice on Capitol Hill. That could be helpful in drawing support from both sides of the political aisle as President Joe Biden fights for an additional $1.9 trillion pandemic fiscal spending package and his coming infrastructure bill.\nThe call for additional aid for U.S. households, businesses and cities hard-hit by the pandemic comes as investors around the globe continue to hunt for any additional upside that might be squeezed out of financial markets, following more than a decade of low rates and easy-money policies and a growing U.S. budget deficit .\nStill, Vaillancourt's team at Putnam sees how U.S. stocks \"could potentially rip higher,\" even though there already are showing \"strong parallels with those heady dot-com days\" that bear watching, including multibillion-dollar valuations for companies with \"little to show for revenue,\" insiders selling equity and the rise of special-purpose acquisition companies, or SPACS, that have raised large sums through initial public offerings.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":319981131,"gmtCreate":1611475364423,"gmtModify":1704860377530,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CFII\">$CF Finance Acquisition Corp II(CFII)$</a>Moving up soon?&nbsp;","listText":"<a href=\"https://laohu8.com/S/CFII\">$CF Finance Acquisition Corp II(CFII)$</a>Moving up soon?&nbsp;","text":"$CF Finance Acquisition Corp II(CFII)$Moving up soon?","images":[{"img":"https://static.tigerbbs.com/b4e2e4167da8926b9ed88a16533a5b39","width":"1080","height":"2256"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/319981131","isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":310876409,"gmtCreate":1611314483201,"gmtModify":1704859507881,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Poised to move soon.&nbsp;","listText":"Poised to move soon.&nbsp;","text":"Poised to move soon.","images":[{"img":"https://static.tigerbbs.com/76191cc406a8417aee88b33d3c6bc5ae","width":"1080","height":"2256"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/310876409","isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":399919917,"gmtCreate":1605892866939,"gmtModify":1704963063311,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/399919917","repostId":"2084284047","repostType":4,"repost":{"id":"2084284047","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1605864360,"share":"https://ttm.financial/m/news/2084284047?lang=en_US&edition=fundamental","pubTime":"2020-11-20 17:26","market":"hk","language":"en","title":"Could Tesla and other auto makers see sales boom from Boris Johnson's ambitious plan for electric vehicles?","url":"https://stock-news.laohu8.com/highlight/detail?id=2084284047","media":"Dow Jones","summary":"Sales of new gasoline and diesel cars will be banned in the U.K. by 2030.\n\nBoris Johnson has release","content":"<blockquote>\n Sales of new gasoline and diesel cars will be banned in the U.K. by 2030.\n</blockquote>\n<p>Boris Johnson has released a plan to kick-start a new green economy in the U.K., including rapidly accelerating the transition to electric vehicles and transforming national infrastructure to support them.</p>\n<p>The prime minister's plan, confirmed on Wednesday, outlines the road map for a \"Green Industrial Revolution\" that will be backed by GBP12 billion ($15.9 billion) in public money, and potentially more than GBP36 billion in private funds, the government said.</p>\n<p>The goal is to create 250,000 jobs by 2030, including 90,000 before the next national election expected in 2024, in renewable energy and green industries.</p>\n<p>One of the key elements of the 10-point plan is to transform the U.K.'s automotive manufacturing sector, the fifth-largest in Europe, into an electric vehicle powerhouse.</p>\n<p>Nissan, Honda, Toyota, Aston Martin, Jaguar Land Rover (owned by India's Tata Motors (500570.BY)), and Mini (owned by BMW ) are among the car companies that manufacture vehicles in the U.K.</p>\n<p>The plan will move up the U.K.'s transition to green mobility by ending the sale of new gasoline and diesel cars and vans by 2030, in favor of battery electric vehicles and full hybrids, with a transition to 100% zero-emissions vehicles by 2035.</p>\n<p>The government previously planned to ban sales of new internal combustion engine vehicles by 2040, and in February Johnson bumped that deadline up to 2035.</p>\n<p>Up to GBP1 billion will be earmarked for supporting the electrification of vehicles and supply chains, including the development of gigafactories to produce batteries.</p>\n<p>The government will also spend GBP1.3 billion to build vehicle-charging infrastructure, and provide GBP582 million to extend grants to reduce the sticker price of plug-in cars, vans, taxis, and motorcycles.</p>\n<p>Battery-powered electric vehicles made up 6.6% of all new vehicles purchased in the U.K. in October, but are on the rise -- they made up just 2.2% of new vehicles purchased in the same month in 2019, according to data from the Society of Motor Manufacturers and Traders.</p>\n<p>Meanwhile, sales of gasoline and diesel cars are falling, according to SMMT data, making up 64.4% of new vehicles purchased in October compared with 85.6% in 2019.</p>\n<p>As an established and specialized manufacturer of electric vehicles with a growing sales presence in the U.K., Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> could stand to benefit from Johnson's new plan.</p>\n<p>Tesla's Model 3 is the bestselling electric car in the U.K., and, according to SMMT data, was the ninth most popular new car purchase in June across all vehicle types.</p>\n<p>Harry Barnick, an analyst at Third Bridge, an investment research consulting firm, said that Johnson's new strategy puts manufacturers a decade behind in developing and rolling out electric vehicles and hybrids for the British car market -- the second largest in Europe, after Germany.</p>\n<p>\"Brands like Volkswagen, who have a healthy pipeline of electric vehicles are well positioned to benefit from this shift,\" Barnick said. \"In contrast, Renault, with its aging electric vehicles will have to aggressively rethink it is product strategy.\"</p>\n<p>Barnick also noted that the ultra-premium segment will be particularly set back, because they have been slower to develop electric and hybrid-electric vehicles.</p>\n<p>\"Brands like Aston Martin, who recently announced a suspension of its electrification strategy in light of COVID, will have to rethink the next 13 years,\" Barnick said.</p>\n<p>However, Barnick said that the policy's extension of new sales for hybrid vehicles until 2035 \"will be a lifeline for brands that are behind the pure-electric innovation curve.\"</p>\n<p>Johnson's plan also includes broader implications for British energy and finance, including quadrupling the current offshore wind power production, focusing on low-carbon hydrogen production, and making the City of London the global center of green finance.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Could Tesla and other auto makers see sales boom from Boris Johnson's ambitious plan for electric vehicles?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCould Tesla and other auto makers see sales boom from Boris Johnson's ambitious plan for electric vehicles?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2020-11-20 17:26</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Sales of new gasoline and diesel cars will be banned in the U.K. by 2030.\n</blockquote>\n<p>Boris Johnson has released a plan to kick-start a new green economy in the U.K., including rapidly accelerating the transition to electric vehicles and transforming national infrastructure to support them.</p>\n<p>The prime minister's plan, confirmed on Wednesday, outlines the road map for a \"Green Industrial Revolution\" that will be backed by GBP12 billion ($15.9 billion) in public money, and potentially more than GBP36 billion in private funds, the government said.</p>\n<p>The goal is to create 250,000 jobs by 2030, including 90,000 before the next national election expected in 2024, in renewable energy and green industries.</p>\n<p>One of the key elements of the 10-point plan is to transform the U.K.'s automotive manufacturing sector, the fifth-largest in Europe, into an electric vehicle powerhouse.</p>\n<p>Nissan, Honda, Toyota, Aston Martin, Jaguar Land Rover (owned by India's Tata Motors (500570.BY)), and Mini (owned by BMW ) are among the car companies that manufacture vehicles in the U.K.</p>\n<p>The plan will move up the U.K.'s transition to green mobility by ending the sale of new gasoline and diesel cars and vans by 2030, in favor of battery electric vehicles and full hybrids, with a transition to 100% zero-emissions vehicles by 2035.</p>\n<p>The government previously planned to ban sales of new internal combustion engine vehicles by 2040, and in February Johnson bumped that deadline up to 2035.</p>\n<p>Up to GBP1 billion will be earmarked for supporting the electrification of vehicles and supply chains, including the development of gigafactories to produce batteries.</p>\n<p>The government will also spend GBP1.3 billion to build vehicle-charging infrastructure, and provide GBP582 million to extend grants to reduce the sticker price of plug-in cars, vans, taxis, and motorcycles.</p>\n<p>Battery-powered electric vehicles made up 6.6% of all new vehicles purchased in the U.K. in October, but are on the rise -- they made up just 2.2% of new vehicles purchased in the same month in 2019, according to data from the Society of Motor Manufacturers and Traders.</p>\n<p>Meanwhile, sales of gasoline and diesel cars are falling, according to SMMT data, making up 64.4% of new vehicles purchased in October compared with 85.6% in 2019.</p>\n<p>As an established and specialized manufacturer of electric vehicles with a growing sales presence in the U.K., Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> could stand to benefit from Johnson's new plan.</p>\n<p>Tesla's Model 3 is the bestselling electric car in the U.K., and, according to SMMT data, was the ninth most popular new car purchase in June across all vehicle types.</p>\n<p>Harry Barnick, an analyst at Third Bridge, an investment research consulting firm, said that Johnson's new strategy puts manufacturers a decade behind in developing and rolling out electric vehicles and hybrids for the British car market -- the second largest in Europe, after Germany.</p>\n<p>\"Brands like Volkswagen, who have a healthy pipeline of electric vehicles are well positioned to benefit from this shift,\" Barnick said. \"In contrast, Renault, with its aging electric vehicles will have to aggressively rethink it is product strategy.\"</p>\n<p>Barnick also noted that the ultra-premium segment will be particularly set back, because they have been slower to develop electric and hybrid-electric vehicles.</p>\n<p>\"Brands like Aston Martin, who recently announced a suspension of its electrification strategy in light of COVID, will have to rethink the next 13 years,\" Barnick said.</p>\n<p>However, Barnick said that the policy's extension of new sales for hybrid vehicles until 2035 \"will be a lifeline for brands that are behind the pure-electric innovation curve.\"</p>\n<p>Johnson's plan also includes broader implications for British energy and finance, including quadrupling the current offshore wind power production, focusing on low-carbon hydrogen production, and making the City of London the global center of green finance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2084284047","content_text":"Sales of new gasoline and diesel cars will be banned in the U.K. by 2030.\n\nBoris Johnson has released a plan to kick-start a new green economy in the U.K., including rapidly accelerating the transition to electric vehicles and transforming national infrastructure to support them.\nThe prime minister's plan, confirmed on Wednesday, outlines the road map for a \"Green Industrial Revolution\" that will be backed by GBP12 billion ($15.9 billion) in public money, and potentially more than GBP36 billion in private funds, the government said.\nThe goal is to create 250,000 jobs by 2030, including 90,000 before the next national election expected in 2024, in renewable energy and green industries.\nOne of the key elements of the 10-point plan is to transform the U.K.'s automotive manufacturing sector, the fifth-largest in Europe, into an electric vehicle powerhouse.\nNissan, Honda, Toyota, Aston Martin, Jaguar Land Rover (owned by India's Tata Motors (500570.BY)), and Mini (owned by BMW ) are among the car companies that manufacture vehicles in the U.K.\nThe plan will move up the U.K.'s transition to green mobility by ending the sale of new gasoline and diesel cars and vans by 2030, in favor of battery electric vehicles and full hybrids, with a transition to 100% zero-emissions vehicles by 2035.\nThe government previously planned to ban sales of new internal combustion engine vehicles by 2040, and in February Johnson bumped that deadline up to 2035.\nUp to GBP1 billion will be earmarked for supporting the electrification of vehicles and supply chains, including the development of gigafactories to produce batteries.\nThe government will also spend GBP1.3 billion to build vehicle-charging infrastructure, and provide GBP582 million to extend grants to reduce the sticker price of plug-in cars, vans, taxis, and motorcycles.\nBattery-powered electric vehicles made up 6.6% of all new vehicles purchased in the U.K. in October, but are on the rise -- they made up just 2.2% of new vehicles purchased in the same month in 2019, according to data from the Society of Motor Manufacturers and Traders.\nMeanwhile, sales of gasoline and diesel cars are falling, according to SMMT data, making up 64.4% of new vehicles purchased in October compared with 85.6% in 2019.\nAs an established and specialized manufacturer of electric vehicles with a growing sales presence in the U.K., Tesla $(TSLA)$ could stand to benefit from Johnson's new plan.\nTesla's Model 3 is the bestselling electric car in the U.K., and, according to SMMT data, was the ninth most popular new car purchase in June across all vehicle types.\nHarry Barnick, an analyst at Third Bridge, an investment research consulting firm, said that Johnson's new strategy puts manufacturers a decade behind in developing and rolling out electric vehicles and hybrids for the British car market -- the second largest in Europe, after Germany.\n\"Brands like Volkswagen, who have a healthy pipeline of electric vehicles are well positioned to benefit from this shift,\" Barnick said. \"In contrast, Renault, with its aging electric vehicles will have to aggressively rethink it is product strategy.\"\nBarnick also noted that the ultra-premium segment will be particularly set back, because they have been slower to develop electric and hybrid-electric vehicles.\n\"Brands like Aston Martin, who recently announced a suspension of its electrification strategy in light of COVID, will have to rethink the next 13 years,\" Barnick said.\nHowever, Barnick said that the policy's extension of new sales for hybrid vehicles until 2035 \"will be a lifeline for brands that are behind the pure-electric innovation curve.\"\nJohnson's plan also includes broader implications for British energy and finance, including quadrupling the current offshore wind power production, focusing on low-carbon hydrogen production, and making the City of London the global center of green finance.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation","text":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation","html":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134962623,"gmtCreate":1622201527662,"gmtModify":1704181362783,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>AMC to the moon&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>AMC to the moon&nbsp;","text":"$AMC Entertainment(AMC)$AMC to the moon","images":[{"img":"https://static.tigerbbs.com/025259f414ec0ae367ce5aa5cb887d56","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/134962623","isVote":1,"tweetType":1,"viewCount":1697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":386516865,"gmtCreate":1613202526157,"gmtModify":1704879418999,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>&nbsp;sfill holding&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>&nbsp;sfill holding&nbsp;","text":"$AMC Entertainment(AMC)$ sfill holding","images":[{"img":"https://static.tigerbbs.com/6df28e4106b8fa8654cbe8fab9de17e1","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/386516865","isVote":1,"tweetType":1,"viewCount":757,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3567570068519334","authorId":"3567570068519334","name":"胜利曙光","avatar":"https://static.tigerbbs.com/ef4fea1c9347fef2d43cbf3fa476b33e","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3567570068519334","idStr":"3567570068519334"},"content":"Still holding too","text":"Still holding too","html":"Still holding too"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":383891451,"gmtCreate":1612862018073,"gmtModify":1704875056117,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>faint","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>faint","text":"$AMC Entertainment(AMC)$faint","images":[{"img":"https://static.tigerbbs.com/190f6d15bc3fbc5ddba26b19b4c3afa0","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/383891451","isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898698812,"gmtCreate":1628490129136,"gmtModify":1703506955585,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898698812","repostId":"2158413272","repostType":4,"repost":{"id":"2158413272","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628489696,"share":"https://ttm.financial/m/news/2158413272?lang=en_US&edition=fundamental","pubTime":"2021-08-09 14:14","market":"us","language":"en","title":"Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd","url":"https://stock-news.laohu8.com/highlight/detail?id=2158413272","media":"Reuters","summary":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt","content":"<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsraeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-09 14:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158413272","content_text":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.\nIsrael began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.\nIsrael's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/BioNTech SE vaccine to more than 240,000 people.\nAbout 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.\nEighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.\nThirty-one percent reported some side effect, the most common being soreness at the injection site.\nAbout 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.\nRan Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"\n\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125687952,"gmtCreate":1624671808276,"gmtModify":1703843242240,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125687952","repostId":"1100072036","repostType":4,"isVote":1,"tweetType":1,"viewCount":1707,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":385691665,"gmtCreate":1613538836357,"gmtModify":1704881775963,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VLDR\">$Velodyne Lidar Inc(VLDR)$</a>&nbsp;coming back up","listText":"<a href=\"https://laohu8.com/S/VLDR\">$Velodyne Lidar Inc(VLDR)$</a>&nbsp;coming back up","text":"$Velodyne Lidar Inc(VLDR)$ coming back up","images":[{"img":"https://static.tigerbbs.com/a1bc60471bf7e264b96225a50de95d34","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/385691665","isVote":1,"tweetType":1,"viewCount":506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":398703506,"gmtCreate":1606956382705,"gmtModify":1704968029634,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AZN\">$AstraZeneca PLC(AZN)$</a>&nbsp;more to come","listText":"<a href=\"https://laohu8.com/S/AZN\">$AstraZeneca PLC(AZN)$</a>&nbsp;more to come","text":"$AstraZeneca PLC(AZN)$ more to come","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/398703506","repostId":"2088677940","repostType":4,"repost":{"id":"2088677940","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1606907640,"share":"https://ttm.financial/m/news/2088677940?lang=en_US&edition=fundamental","pubTime":"2020-12-02 19:14","market":"hk","language":"en","title":"As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2088677940","media":"Dow Jones","summary":"MW UPDATE: As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax tr","content":"<p>MW UPDATE: As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial</p>\n<p>Pierre Briançon</p>\n<p>'No, I never considered it was risky, and no, of course, I'm not getting paid. I just received my second shot a few days ago,' writes Pierre Briançon of volunteering for a vaccine trial in London.</p>\n<p>The first question that came to my friends' minds was whether I'd really thought about the possible dangers. Two of them, more focused on worldly matters, asked whether at least I was being paid.</p>\n<p>That was a month ago, a few days before I went to London's Royal Free Hospital to have my first shot as a volunteer in the Phase 3 trial of a coronavirus vaccine. Now the same friends seem to wonder whether I have chosen the right horse, but they don't venture to ask me, for fear of hurting my feelings.</p>\n<p>The vaccine I'm trying is developed by Novavax <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a>, a U.S. biotech company, and it was the second <a href=\"https://laohu8.com/S/AONE\">one</a> late-stage trials in the U.K., as well.</p>\n<p>But all the news in recent weeks has been on the three vaccines that had reached 90% efficacy or higher in their late-stage trial. No news from Novavax -- which is natural because its wide-scale trial started later than the others -- so the candidate I have come to consider \"my\" vaccine, looks like it's running fourth at best ...</p>\n<p>Key Words:Dr. Fauci on Cuomo's decision to review vaccines for New Yorkers after FDA approval: 'Trust the process'</p>\n<p>In reality, this is all silly. I just received my second shot a few days ago. The answers to all of my friends' questions are negative. No, I never considered it was risky. No, of course I'm not getting paid. And, as all the experts would tell you, it does make very much sense for Novavax and the dozens of other vaccine candidates to continue with the trials -- even if three other vaccines have already shown results, something that was not expected to happen so fast when the world was confronted earlier this year with the calamity of the first coronavirus wave.</p>\n<p>It's not that I want to cheer my team against all odds, as supporters stick with their football club for better and for worse. But ever since I got a phone call asking me to confirm the decision I'd made in early summer to join the register of vaccine volunteers for the NHS, the U.K's health service, I have, of course, become interested not only in the vaccine but in the fate of the U.S. biotech that is developing it.</p>\n<p>So I know that Novavax is based in Maryland, and that the smart move -- silly me -- would have been to buy its shares in January instead of receiving its vaccine in October. The stock is up 2,200% since the beginning of the year (no, I didn't throw an extra 0 on that -- put differently, the share price has been multiplied by 23). No underdog there, at least. And that's for a company that is yet to put an actual vaccine on the market.</p>\n<p>The overall reason for the lack of anxiety or \"fear of danger,\" as my friends would put it, about being inoculated with an unknown substance is that you're being accompanied most of the way by the NHS doctors and nurses who manage the trial. Everything is explained, options are offered (you can leave whenever you feel like it, without having to give a reason), test kits are distributed if case symptoms occur, and an app is there to keep a daily diary if they do.</p>\n<p>Then there's a monthly \"vaccine registry\" newsletter, the latest of which insisted that it does make sense to keep researching and trying: Divya Chadha Manek, the head of clinical trials of the U.K. vaccine task force, explained to me (and a few thousand others) first that we will need many vaccines both globally and in the U.K. Second, and this may be even more important, not all vaccines will be found appropriate for all people. \"Basically, we can't put all our eggs in <a href=\"https://laohu8.com/S/AONE.U\">one</a> basket,\" Divya wrote.</p>\n<p>Besides, this is still, very literally, a trial-and-error process. Three vaccines that seem to have proven their efficacy -- from Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, the U.S. pharma group, in collaboration with Germany's BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>; biotech Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>; and the AstraZeneca--Oxford collaborative effort. But questions started being raised about both the process and implementation of AstraZeneca's Phase 3 trial just a few days after it published its preliminary results. This could mean at the very least that the road to an effective vaccine may be longer and bumpier than hoped for in the optimism of the last two weeks.</p>\n<p>So I still root for Novavax, which will take another few months to tell us about the trial result, and just extended its pool of volunteers in the U.K. from 10,000 to 15,000 -- even though I may not even be vaccinated at all: Half of us were injected with a placebo, an inactive saline solution looking like a vaccine dose that will have no effect on our immune system. This is a \"double blind\" trial where even the doctors and nurses following us do not know whether we got the vaccine.</p>\n<p>So I'm left wondering, trying not to become a hypochondriac who takes the smallest signs of unease for possible symptoms. Is my left arm hurting after the second shot? Is that a serious headache? And why did I just cough?</p>\n<p>Dispatches from a Pandemic:Pope Francis takes aim at anti-mask protesters: 'They are incapable of moving outside of their own little world'</p>\n<p>-; 415-439-6400; AskNewswires@dowjones.com</p>\n<p><a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires</p>\n<p>December 02, 2020 06:14 ET (11:14 GMT)</p>\n<p>Copyright (c) 2020 Dow Jones &amp; Company, Inc.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2020-12-02 19:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW UPDATE: As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial</p>\n<p>Pierre Briançon</p>\n<p>'No, I never considered it was risky, and no, of course, I'm not getting paid. I just received my second shot a few days ago,' writes Pierre Briançon of volunteering for a vaccine trial in London.</p>\n<p>The first question that came to my friends' minds was whether I'd really thought about the possible dangers. Two of them, more focused on worldly matters, asked whether at least I was being paid.</p>\n<p>That was a month ago, a few days before I went to London's Royal Free Hospital to have my first shot as a volunteer in the Phase 3 trial of a coronavirus vaccine. Now the same friends seem to wonder whether I have chosen the right horse, but they don't venture to ask me, for fear of hurting my feelings.</p>\n<p>The vaccine I'm trying is developed by Novavax <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a>, a U.S. biotech company, and it was the second <a href=\"https://laohu8.com/S/AONE\">one</a> late-stage trials in the U.K., as well.</p>\n<p>But all the news in recent weeks has been on the three vaccines that had reached 90% efficacy or higher in their late-stage trial. No news from Novavax -- which is natural because its wide-scale trial started later than the others -- so the candidate I have come to consider \"my\" vaccine, looks like it's running fourth at best ...</p>\n<p>Key Words:Dr. Fauci on Cuomo's decision to review vaccines for New Yorkers after FDA approval: 'Trust the process'</p>\n<p>In reality, this is all silly. I just received my second shot a few days ago. The answers to all of my friends' questions are negative. No, I never considered it was risky. No, of course I'm not getting paid. And, as all the experts would tell you, it does make very much sense for Novavax and the dozens of other vaccine candidates to continue with the trials -- even if three other vaccines have already shown results, something that was not expected to happen so fast when the world was confronted earlier this year with the calamity of the first coronavirus wave.</p>\n<p>It's not that I want to cheer my team against all odds, as supporters stick with their football club for better and for worse. But ever since I got a phone call asking me to confirm the decision I'd made in early summer to join the register of vaccine volunteers for the NHS, the U.K's health service, I have, of course, become interested not only in the vaccine but in the fate of the U.S. biotech that is developing it.</p>\n<p>So I know that Novavax is based in Maryland, and that the smart move -- silly me -- would have been to buy its shares in January instead of receiving its vaccine in October. The stock is up 2,200% since the beginning of the year (no, I didn't throw an extra 0 on that -- put differently, the share price has been multiplied by 23). No underdog there, at least. And that's for a company that is yet to put an actual vaccine on the market.</p>\n<p>The overall reason for the lack of anxiety or \"fear of danger,\" as my friends would put it, about being inoculated with an unknown substance is that you're being accompanied most of the way by the NHS doctors and nurses who manage the trial. Everything is explained, options are offered (you can leave whenever you feel like it, without having to give a reason), test kits are distributed if case symptoms occur, and an app is there to keep a daily diary if they do.</p>\n<p>Then there's a monthly \"vaccine registry\" newsletter, the latest of which insisted that it does make sense to keep researching and trying: Divya Chadha Manek, the head of clinical trials of the U.K. vaccine task force, explained to me (and a few thousand others) first that we will need many vaccines both globally and in the U.K. Second, and this may be even more important, not all vaccines will be found appropriate for all people. \"Basically, we can't put all our eggs in <a href=\"https://laohu8.com/S/AONE.U\">one</a> basket,\" Divya wrote.</p>\n<p>Besides, this is still, very literally, a trial-and-error process. Three vaccines that seem to have proven their efficacy -- from Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, the U.S. pharma group, in collaboration with Germany's BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>; biotech Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>; and the AstraZeneca--Oxford collaborative effort. But questions started being raised about both the process and implementation of AstraZeneca's Phase 3 trial just a few days after it published its preliminary results. This could mean at the very least that the road to an effective vaccine may be longer and bumpier than hoped for in the optimism of the last two weeks.</p>\n<p>So I still root for Novavax, which will take another few months to tell us about the trial result, and just extended its pool of volunteers in the U.K. from 10,000 to 15,000 -- even though I may not even be vaccinated at all: Half of us were injected with a placebo, an inactive saline solution looking like a vaccine dose that will have no effect on our immune system. This is a \"double blind\" trial where even the doctors and nurses following us do not know whether we got the vaccine.</p>\n<p>So I'm left wondering, trying not to become a hypochondriac who takes the smallest signs of unease for possible symptoms. Is my left arm hurting after the second shot? Is that a serious headache? And why did I just cough?</p>\n<p>Dispatches from a Pandemic:Pope Francis takes aim at anti-mask protesters: 'They are incapable of moving outside of their own little world'</p>\n<p>-; 415-439-6400; AskNewswires@dowjones.com</p>\n<p><a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires</p>\n<p>December 02, 2020 06:14 ET (11:14 GMT)</p>\n<p>Copyright (c) 2020 Dow Jones &amp; Company, Inc.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","NVAX":"诺瓦瓦克斯医药","AZN":"阿斯利康","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2088677940","content_text":"MW UPDATE: As U.K. is first to approve a COVID vaccine, this is why I volunteered for the Novavax trial\nPierre Briançon\n'No, I never considered it was risky, and no, of course, I'm not getting paid. I just received my second shot a few days ago,' writes Pierre Briançon of volunteering for a vaccine trial in London.\nThe first question that came to my friends' minds was whether I'd really thought about the possible dangers. Two of them, more focused on worldly matters, asked whether at least I was being paid.\nThat was a month ago, a few days before I went to London's Royal Free Hospital to have my first shot as a volunteer in the Phase 3 trial of a coronavirus vaccine. Now the same friends seem to wonder whether I have chosen the right horse, but they don't venture to ask me, for fear of hurting my feelings.\nThe vaccine I'm trying is developed by Novavax $(NVAX)$, a U.S. biotech company, and it was the second one late-stage trials in the U.K., as well.\nBut all the news in recent weeks has been on the three vaccines that had reached 90% efficacy or higher in their late-stage trial. No news from Novavax -- which is natural because its wide-scale trial started later than the others -- so the candidate I have come to consider \"my\" vaccine, looks like it's running fourth at best ...\nKey Words:Dr. Fauci on Cuomo's decision to review vaccines for New Yorkers after FDA approval: 'Trust the process'\nIn reality, this is all silly. I just received my second shot a few days ago. The answers to all of my friends' questions are negative. No, I never considered it was risky. No, of course I'm not getting paid. And, as all the experts would tell you, it does make very much sense for Novavax and the dozens of other vaccine candidates to continue with the trials -- even if three other vaccines have already shown results, something that was not expected to happen so fast when the world was confronted earlier this year with the calamity of the first coronavirus wave.\nIt's not that I want to cheer my team against all odds, as supporters stick with their football club for better and for worse. But ever since I got a phone call asking me to confirm the decision I'd made in early summer to join the register of vaccine volunteers for the NHS, the U.K's health service, I have, of course, become interested not only in the vaccine but in the fate of the U.S. biotech that is developing it.\nSo I know that Novavax is based in Maryland, and that the smart move -- silly me -- would have been to buy its shares in January instead of receiving its vaccine in October. The stock is up 2,200% since the beginning of the year (no, I didn't throw an extra 0 on that -- put differently, the share price has been multiplied by 23). No underdog there, at least. And that's for a company that is yet to put an actual vaccine on the market.\nThe overall reason for the lack of anxiety or \"fear of danger,\" as my friends would put it, about being inoculated with an unknown substance is that you're being accompanied most of the way by the NHS doctors and nurses who manage the trial. Everything is explained, options are offered (you can leave whenever you feel like it, without having to give a reason), test kits are distributed if case symptoms occur, and an app is there to keep a daily diary if they do.\nThen there's a monthly \"vaccine registry\" newsletter, the latest of which insisted that it does make sense to keep researching and trying: Divya Chadha Manek, the head of clinical trials of the U.K. vaccine task force, explained to me (and a few thousand others) first that we will need many vaccines both globally and in the U.K. Second, and this may be even more important, not all vaccines will be found appropriate for all people. \"Basically, we can't put all our eggs in one basket,\" Divya wrote.\nBesides, this is still, very literally, a trial-and-error process. Three vaccines that seem to have proven their efficacy -- from Pfizer $(PFE)$, the U.S. pharma group, in collaboration with Germany's BioNTech $(BNTX)$; biotech Moderna $(MRNA)$; and the AstraZeneca--Oxford collaborative effort. But questions started being raised about both the process and implementation of AstraZeneca's Phase 3 trial just a few days after it published its preliminary results. This could mean at the very least that the road to an effective vaccine may be longer and bumpier than hoped for in the optimism of the last two weeks.\nSo I still root for Novavax, which will take another few months to tell us about the trial result, and just extended its pool of volunteers in the U.K. from 10,000 to 15,000 -- even though I may not even be vaccinated at all: Half of us were injected with a placebo, an inactive saline solution looking like a vaccine dose that will have no effect on our immune system. This is a \"double blind\" trial where even the doctors and nurses following us do not know whether we got the vaccine.\nSo I'm left wondering, trying not to become a hypochondriac who takes the smallest signs of unease for possible symptoms. Is my left arm hurting after the second shot? Is that a serious headache? And why did I just cough?\nDispatches from a Pandemic:Pope Francis takes aim at anti-mask protesters: 'They are incapable of moving outside of their own little world'\n-; 415-439-6400; AskNewswires@dowjones.com\n$(END)$ Dow Jones Newswires\nDecember 02, 2020 06:14 ET (11:14 GMT)\nCopyright (c) 2020 Dow Jones & Company, Inc.","news_type":1,"symbols_score_info":{"JNJ":0.9,"MRNA":0.9,"NVAX":0.9,"AZN":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":391237580,"gmtCreate":1606704326241,"gmtModify":1704966376672,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/391237580","repostId":"2086348736","repostType":4,"repost":{"id":"2086348736","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1062363208","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1606470556,"share":"https://ttm.financial/m/news/2086348736?lang=en_US&edition=fundamental","pubTime":"2020-11-27 17:49","market":"us","language":"en","title":"Malaysia secures 12.8 mln doses of Pfizer vaccine, delivery from Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2086348736","media":"Reuters","summary":"KUALA LUMPUR, Nov 27 (Reuters) - Malaysia is expected to receive its first COVID-19 vaccines from Pf","content":"<p>KUALA LUMPUR, Nov 27 (Reuters) - Malaysia is expected to receive its first COVID-19 vaccines from Pfizer in the first quarter of 2021 after signing a deal for 12.8 million doses from the U.S. manufacturer, Prime Minister Muhyiddin Yassin said on Friday.</p>\n<p>The deal is expected to cover 6.4 million Malaysians, or 20 percent of the population, with another 10 percent to be covered under Malaysia's participation in the global COVAX facility, backed by the World Health Organization.</p>\n<p>Pfizer has agreed to deliver the first <a href=\"https://laohu8.com/S/AONE\">one</a> million doses in the first quarter of 2021, with 1.7 million doses, 5.8 million and 4.3 million to follow in subsequent quarters, Muhyiddin said.</p>\n<p>The vaccination programme would prioritise \"high-risk groups... including frontliners, senior citizens, and those with non-communicable diseases, such as heart diseases, diabetes,\" he said during a televised news conference.</p>\n<p>The Pfizer vaccine still requires approvals from regulator including the U.S. Food and Drug Administration and Malaysia's Health Ministry before it can be distributed, Muhyiddin said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Malaysia secures 12.8 mln doses of Pfizer vaccine, delivery from Q1</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMalaysia secures 12.8 mln doses of Pfizer vaccine, delivery from Q1\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1062363208\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2020-11-27 17:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>KUALA LUMPUR, Nov 27 (Reuters) - Malaysia is expected to receive its first COVID-19 vaccines from Pfizer in the first quarter of 2021 after signing a deal for 12.8 million doses from the U.S. manufacturer, Prime Minister Muhyiddin Yassin said on Friday.</p>\n<p>The deal is expected to cover 6.4 million Malaysians, or 20 percent of the population, with another 10 percent to be covered under Malaysia's participation in the global COVAX facility, backed by the World Health Organization.</p>\n<p>Pfizer has agreed to deliver the first <a href=\"https://laohu8.com/S/AONE\">one</a> million doses in the first quarter of 2021, with 1.7 million doses, 5.8 million and 4.3 million to follow in subsequent quarters, Muhyiddin said.</p>\n<p>The vaccination programme would prioritise \"high-risk groups... including frontliners, senior citizens, and those with non-communicable diseases, such as heart diseases, diabetes,\" he said during a televised news conference.</p>\n<p>The Pfizer vaccine still requires approvals from regulator including the U.S. Food and Drug Administration and Malaysia's Health Ministry before it can be distributed, Muhyiddin said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2086348736","content_text":"KUALA LUMPUR, Nov 27 (Reuters) - Malaysia is expected to receive its first COVID-19 vaccines from Pfizer in the first quarter of 2021 after signing a deal for 12.8 million doses from the U.S. manufacturer, Prime Minister Muhyiddin Yassin said on Friday.\nThe deal is expected to cover 6.4 million Malaysians, or 20 percent of the population, with another 10 percent to be covered under Malaysia's participation in the global COVAX facility, backed by the World Health Organization.\nPfizer has agreed to deliver the first one million doses in the first quarter of 2021, with 1.7 million doses, 5.8 million and 4.3 million to follow in subsequent quarters, Muhyiddin said.\nThe vaccination programme would prioritise \"high-risk groups... including frontliners, senior citizens, and those with non-communicable diseases, such as heart diseases, diabetes,\" he said during a televised news conference.\nThe Pfizer vaccine still requires approvals from regulator including the U.S. Food and Drug Administration and Malaysia's Health Ministry before it can be distributed, Muhyiddin said.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898698113,"gmtCreate":1628490103032,"gmtModify":1703506955423,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>&nbsp;when is this gonna start moving?&nbsp;","listText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>&nbsp;when is this gonna start moving?&nbsp;","text":"$Proterra Inc.(PTRA)$ when is this gonna start moving?","images":[{"img":"https://static.tigerbbs.com/e92e515790b36221ea69f23ec118eb90","width":"1176","height":"2091"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898698113","isVote":1,"tweetType":1,"viewCount":1802,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":162579628,"gmtCreate":1624069582664,"gmtModify":1703828121467,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Solid Uptrend. Nice to hold","listText":"Solid Uptrend. Nice to hold","text":"Solid Uptrend. Nice to hold","images":[{"img":"https://static.tigerbbs.com/702f12b398d11c5c3f9fe42025a6e0d3","width":"1080","height":"3021"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162579628","isVote":1,"tweetType":1,"viewCount":1896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":325495703,"gmtCreate":1615910671202,"gmtModify":1704788429833,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GNOG\">$Golden Nugget Online Gaming, Inc.(GNOG)$</a>sweet","listText":"<a href=\"https://laohu8.com/S/GNOG\">$Golden Nugget Online Gaming, Inc.(GNOG)$</a>sweet","text":"$Golden Nugget Online Gaming, Inc.(GNOG)$sweet","images":[{"img":"https://static.tigerbbs.com/f2175d49aa0cb0dcad79a965f9560cb2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325495703","isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":322470890,"gmtCreate":1615823180610,"gmtModify":1704787179066,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Resistant","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Resistant","text":"$Palantir Technologies Inc.(PLTR)$Resistant","images":[{"img":"https://static.tigerbbs.com/54d7babda19ab683c6cbb784cec56b51","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322470890","isVote":1,"tweetType":1,"viewCount":763,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":391160461,"gmtCreate":1606499450153,"gmtModify":1704966014705,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/391160461","repostId":"1164032336","repostType":4,"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898696118,"gmtCreate":1628490156434,"gmtModify":1703506956734,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Moving up?&nbsp;","listText":"Moving up?&nbsp;","text":"Moving up?","images":[{"img":"https://static.tigerbbs.com/1ec0ed27e46e45e9b203824a5eb3814e","width":"1176","height":"2548"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898696118","isVote":1,"tweetType":1,"viewCount":1763,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125685988,"gmtCreate":1624671744544,"gmtModify":1703843239114,"author":{"id":"3567846245354832","authorId":"3567846245354832","name":"Kliensberg","avatar":"https://static.tigerbbs.com/5e228857fdbe83cbdfd2cc179fe84ff8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567846245354832","idStr":"3567846245354832"},"themes":[],"htmlText":"Starting to move&nbsp;","listText":"Starting to move&nbsp;","text":"Starting to move","images":[{"img":"https://static.tigerbbs.com/6998f7db0638d20fa40c753e04a4f0ac","width":"1080","height":"3528"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125685988","isVote":1,"tweetType":1,"viewCount":1655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}